I3 RESEARCH
DEAD

Serial Number

78318973

Owner

RAVEN HOLDCO, LLC

Attorney

Robert G. Schuler

First Use Date

Nov 3, 2003

Filing Date

Oct 27, 2003

Add to watchlist:

No watchlists yet
View on USPTO

I3 RESEARCH Trademark

Serial Number: 78318973 • Registration: 2979431

I3 RESEARCH is a trademark filed by RAVEN HOLDCO, LLC on October 27, 2003. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

RAVEN HOLDCO, LLC (6 trademarks)

500 ATRIUM DRIVE
SOMERSET, NJ 08873

Entity Type: 16

INGENIX, INC. (192 trademarks)

12125 TECHNOLOGY DRIVE
EDEN PRAIRIE, MN 55344

Entity Type: 03

Trademark Details

Filing Date

October 27, 2003

Registration Date

July 26, 2005

First Use Anywhere

November 3, 2003

First Use in Commerce

November 3, 2003

Published for Opposition

August 24, 2004

Cancellation Date

March 2, 2012

Goods & Services

Training clinical trial site personnel in the use of tests and rating systems for drug protocol requirements; and training clinical trial site personnel in the use of medical and research equipment required by drug protocols

Management services of a business nature for clinical trials in the field of investigational drugs, namely, arranging for sites to perform clinical trials, arranging for the import, packaging, shipping, labeling and distribution of drugs and other investigational supplies to and from the clinical trial sites, arranging for the central collection of laboratory specimens from clinical trial sites, making any and all filings required by the Food and Drug Administration for investigational new drugs, preparing statistical reports resulting from clinical trials

Management services of a scientific and technical nature for clinical trials in the field of investigational drugs, namely, conducting clinical protocols and trials for others; consulting services regarding scientific and technical aspects of clinical trials of investigational drugs, namely, advising others on conducting clinical protocols and trials and the regulatory requirements of the Food and Drug administration; technical writing for others of clinical report forms which are required by clinical trial drug protocols; technical writing for others of clinical trial reports; database development services to process data collected from clinical trials

Filing History

CANCELLED SEC. 8 (6-YR)
Mar 2, 2012 C8..
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 21, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 21, 2011 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 21, 2011 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2011 TCCA
REGISTERED-PRINCIPAL REGISTER
Jul 26, 2005 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Apr 11, 2005 REGV
ASSIGNED TO LIE
Apr 8, 2005 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 4, 2005 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 4, 2005 SUPC
USE AMENDMENT FILED
Mar 8, 2005 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 8, 2005 EISU
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 16, 2004 NOAM
PUBLISHED FOR OPPOSITION
Aug 24, 2004 PUBO
NOTICE OF PUBLICATION
Aug 4, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 10, 2004 CNSA
EXAMINERS AMENDMENT MAILED
Jun 4, 2004 CNEA
NON-FINAL ACTION MAILED
May 24, 2004 CNRT
ASSIGNED TO EXAMINER
May 9, 2004 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2004 CRFA
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 25, 2004 PARI
NEW APPLICATION ENTERED
Nov 20, 2003 NWAP